---
annotations:
- type: Pathway Ontology
  value: glioma pathway
- type: Pathway Ontology
  value: epidermal growth factor/neuregulin signaling pathway
- type: Pathway Ontology
  value: phosphatidylinositol 3-kinase class II signaling pathway
- type: Cell Type Ontology
  value: glioblast
- type: Pathway Ontology
  value: Arf family mediated signaling pathway
- type: Pathway Ontology
  value: the extracellular signal-regulated Raf/Mek/Erk signaling pathway
- type: Pathway Ontology
  value: phosphatidylinositol 3-kinase class I signaling pathway
- type: Pathway Ontology
  value: fibroblast growth factor signaling pathway
- type: Pathway Ontology
  value: protein kinase C (PKC) signaling pathway
- type: Disease Ontology
  value: brain cancer
- type: Disease Ontology
  value: glioblastoma
- type: Pathway Ontology
  value: p53 signaling pathway
- type: Disease Ontology
  value: cancer
authors:
- AlexanderPico
- MaintBot
- Ddigles
- Mkutmon
- Khanspers
- Egonw
- Elisson nl
- Fehrhart
- Eweitz
description: 'The most frequently altered genes in glioblastoma. This pathway originally
  accompanied the 2008 Nature publication on the comprehensive genomic characterization
  of human glioblastoma genes and core pathways by TCGA, The Cancer Genome Atlas (see
  Bibliography).  Assembled from literature and public pathway database resources,
  this representation can easily be kept up to date at WikiPathways.org.  Sources:
  [http://cbio.mskcc.org/cancergenomics/gbm/pathways/GBM_pathway_20080708.pdf cBio
  Cancer Genomics Portal]  Proteins on this pathway have targeted assays available
  via the [https://assays.cancer.gov/available_assays?wp_id=WP2261 CPTAC Assay Portal]'
last-edited: 2021-05-27
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP2261
- /instance/WP2261
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP2261.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'The most frequently altered genes in glioblastoma. This pathway originally
    accompanied the 2008 Nature publication on the comprehensive genomic characterization
    of human glioblastoma genes and core pathways by TCGA, The Cancer Genome Atlas
    (see Bibliography).  Assembled from literature and public pathway database resources,
    this representation can easily be kept up to date at WikiPathways.org.  Sources:
    [http://cbio.mskcc.org/cancergenomics/gbm/pathways/GBM_pathway_20080708.pdf cBio
    Cancer Genomics Portal]  Proteins on this pathway have targeted assays available
    via the [https://assays.cancer.gov/available_assays?wp_id=WP2261 CPTAC Assay Portal]'
  keywords:
  - HRAS
  - NRAS
  - PI(3)P
  - CDKN1A
  - FGFR1
  - LPA
  - TP53
  - NF1
  - PLCG2
  - RAF1
  - PDGFRB
  - CDKN2C
  - PDPK1
  - TSC1
  - RB1
  - PRKCG
  - MET
  - GAB1
  - ARF
  - CBL
  - PRKCB
  - MAP2K6
  - CDK6
  - AKT3
  - GRB2
  - PLCG1
  - MAP2K5
  - PTEN
  - DNA Repair
  - MAP2K2
  - PIK3CB
  - FOXO1
  - Cell Survival
  - PIK3R1
  - FOXO3
  - CCNE1
  - MAP2K3
  - FGFR2
  - MDM4
  - MAPK3
  - CDK2
  - ATM
  - ERBB3
  - PRKCA
  - Apoptosis
  - Cell Migration
  - BRCA1
  - PIK3C2A
  - MDM2
  - MAPK1
  - CDKN2B
  - G1/S Progression
  - CDK4
  - G2/M Arrest
  - TSC2
  - PRKCZ
  - ERBB2
  - CCND1
  - MAP2K7
  - PIK3C2B
  - BRAF
  - EP300
  - P16
  - BRCA2
  - PIK3CA
  - ARAF
  - PIK3C2G
  - PRKCI
  - Cell Cycle Progression
  - EGFR
  - MAP2K1
  - PRKCD
  - AKT1
  - PRKCH
  - IRS1
  - PDGFRA
  - SRC
  - IGF1R
  - PIK3R2
  - AKT2
  - FOXO4
  - MSH6
  - PIK3CD
  - MIR21
  - PIP3
  - CDKN1B
  - SPRY2
  - KRAS
  - ERRFI1
  - MAP2K4
  - PIK3CG
  - E2F1
  - CCND2
  - PRKCQ
  license: CC0
  name: Glioblastoma signaling pathways
seo: CreativeWork
title: Glioblastoma signaling pathways
wpid: WP2261
---